Arbutus Biopharma Corp. (ABUS)
4.45
-0.11
(-2.41%)
USD |
NASDAQ |
Oct 02, 16:00
4.475
+0.02
(+0.56%)
After-Hours: 20:00
Arbutus Biopharma Market Cap : 879.47M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 879.47M |
| October 01, 2026 | 901.21M |
| September 30, 2026 | 944.69M |
| September 29, 2026 | 926.90M |
| September 28, 2026 | 960.50M |
| September 25, 2026 | 958.53M |
| September 24, 2026 | 964.45M |
| September 23, 2026 | 958.53M |
| September 22, 2026 | 990.15M |
| September 21, 2026 | 988.17M |
| September 18, 2026 | 990.15M |
| September 17, 2026 | 1.002B |
| September 16, 2026 | 998.05M |
| September 15, 2026 | 1.000B |
| September 14, 2026 | 1.014B |
| September 11, 2026 | 1.012B |
| September 10, 2026 | 1.012B |
| September 09, 2026 | 1.022B |
| September 08, 2026 | 1.024B |
| September 04, 2026 | 1.018B |
| September 03, 2026 | 1.012B |
| September 02, 2026 | 1.008B |
| September 01, 2026 | 1.006B |
| August 31, 2026 | 1.004B |
| August 28, 2026 | 1.002B |
| Date | Value |
|---|---|
| August 27, 2026 | 1.022B |
| August 26, 2026 | 1.026B |
| August 25, 2026 | 1.028B |
| August 24, 2026 | 1.028B |
| August 21, 2026 | 1.030B |
| August 20, 2026 | 942.71M |
| August 19, 2026 | 984.22M |
| August 18, 2026 | 956.55M |
| August 17, 2026 | 930.86M |
| August 14, 2026 | 922.95M |
| August 13, 2026 | 905.16M |
| August 12, 2026 | 907.14M |
| August 11, 2026 | 922.95M |
| August 10, 2026 | 907.14M |
| August 07, 2026 | 915.05M |
| August 06, 2026 | 894.14M |
| August 05, 2026 | 909.90M |
| August 04, 2026 | 870.51M |
| August 03, 2026 | 858.69M |
| July 31, 2026 | 854.75M |
| July 30, 2026 | 868.54M |
| July 29, 2026 | 844.91M |
| July 28, 2026 | 868.54M |
| July 27, 2026 | 868.54M |
| July 24, 2026 | 862.63M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Insmed, Inc. | 24.26B |
| Pfizer Inc. | 158.43B |
| Gossamer Bio, Inc. | 65.44M |
| Legend Biotech Corp. | 3.598B |
| ACADIA Pharmaceuticals, Inc. | 3.434B |
Market Cap Related Metrics
| PE Ratio | 5.680 |
| PS Ratio | 4.757 |
| Price to Book Value | 3.399 |
| Price | 4.45 |
| Earnings Yield | 17.60% |
| Operating PE Ratio | 5.863 |
| Normalized PE Ratio | 5.723 |